A protein phosphatase is involved in the cholinergic suppression of the Ca2+-activated K+ current sI(AHP) in hippocampal pyramidal neurons

Neuropharmacology

Volumn 39, Issue 7, 2000, Pages 1274-1283

  Krause, Michael ^a   Pedarzani, Paola ^a  

^a MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

Author keywords

CA1 neurons; cGMP; cGMP dependent protein kinase; Muscarinic; Phosphatase; Slow afterhyperpolarization

Indexed keywords

6 ANILINO 5,8 QUINOLINEQUINONE; BICUCULLINE; CARBACHOL; CYANOGINOSIN; CYANOGINOSIN LR; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; GUANINE DERIVATIVE; GUANINE NUCLEOTIDE BINDING PROTEIN; INOSITOL TRISPHOSPHATE; KT 5823; MUSCARINIC AGENT; MUSCARINIC RECEPTOR; N ACETYL S NITROSOPENICILLAMINE; N(G) NITROARGININE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PHOSPHOPROTEIN PHOSPHATASE; PICROTOXIN; PROTEIN KINASE C; TACROLIMUS;

AFTERHYPERPOLARIZATION; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DRUG EFFECT; HIPPOCAMPUS; NONHUMAN; POTASSIUM CURRENT; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; SECOND MESSENGER; SIGNAL TRANSDUCTION;

ANIMALS; CALCIUM; CARBACHOL; CYCLIC AMP; CYCLIC GMP-DEPENDENT PROTEIN KINASES; ENZYME INHIBITORS; GUANYLATE CYCLASE; HIPPOCAMPUS; INOSITOL 1,4,5-TRISPHOSPHATE; MALE; MEMBRANE POTENTIALS; MUSCARINIC AGONISTS; PARASYMPATHETIC NERVOUS SYSTEM; PARASYMPATHOMIMETICS; PATCH-CLAMP TECHNIQUES; PHOSPHOLIPASE C; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN KINASE INHIBITORS; PYRAMIDAL CELLS; RATS; RATS, WISTAR;

EID: 0034062912     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(99)00227-0     Document Type: Article

References (63)

1. + currents in frog cardiac myocytes. Br. J. Pharmacol. 121:1997;1369-1377.
2. Agopyan N., Krnjevic K. Muscarinic actions in hippocampus are probably not mediated by cGMP. Brain Res. 525:1990;294-299.
3. Ahmad Z., Green F.J., Subuhi H.S., Watanabe A.M. Autonomic regulation of type 1 protein phosphatase in cardiac muscle. J. Biol. Chem. 264:1989;3859-3863.
4. Alfonzo M.J., de Becemberg I.L., de Villaroel S.S., de Herrera V.N., Misle A.J., de Alfonzo R.G. Two opposite signal transducing mechanisms regulate a G-protein-coupled guanylyl cyclase. Arch. Biochem. Biophys. 350:1998;19-25.
5. Ambrosini A., Meldolesi J. Muscarinic and quisqualate receptor-induced phosphoinositide hydrolysis in primary cultures of striatal and hippocampal neurons. Evidence for differential mechanisms of activation. J. Neurochem. 53:1989;825-833.
6. Black A.C., Sandquist D., West J.R., Wamsley J.K., Williams T.H. Muscarinic cholinergic stimulation increases cyclic GMP levels in rat hippocampus. J. Neurochem. 33:1979;1165-1168.
7. Bland B.H. The physiology and pharmacology of hippocampal formation theta rhythms. Prog. Neurobiol. 26:1986;1-54.
8. Blanton M.G., Lo Turco J.J., Kriegstein A.R. Whole cell recording from neurons in slices of reptilian and mammalian cerebral cortex. J. Neurosci. Meth. 30:1989;203-210.
9. Blitzer R.D., Gil O., Landau E.M. Cholinergic stimulation enhances long-term potentiation in the CA1 region of rat hippocampus. Neurosci. Lett. 119:1990;207-210.
10. Blitzer R.D., Wong T., Nouranifar R., Landau E.M. The cholinergic inhibition of afterhyperpolarization in rat hippocampus is independent of cAMP-dependent protein kinase. Brain Res. 646:1994;312-314.
11. Caeser M., Brown D.A., Gähwiler B.H., Knöpfel T. Characterization of a calcium-dependent current generating a slow afterdepolarization of CA3 pyramidal cells in rat hippocampal slice cultures. Eur. J. Neurosci. 5:1993;560-569.
12. Cantrell A.R., Ma J.Y., Scheuer T., Catterall W.A. Muscarinic modulation of sodium current by activation of protein kinase C in rat hippocampal neurons. Neuron. 16:1996;1019-1026.
13. Caulfield M.P. Muscarinic receptors - Characterization, coupling and function. Pharmac. Ther. 58:1993;319-379.
14. Cole A.E., Nicoll R.A. Acetylcholine mediates a slow synaptic potential in hippocampal pyramidal cells. Science. 221:1983;1299-1301.
15. Cole A.E., Nicoll R.A. The pharmacology of cholinergic excitatory responses in hippocampal pyramidal cells. Brain Res. 305:1984;283-290.
16. Colino A., Halliwell J.V. Carbachol potentiates Q current and activates a calcium-dependent non-specific conductance in rat hippocampus in vitro. Eur. J. Neurosci. 5:1993;1198-1209.
17. 2+ stores in rat sympathetic neurons. Proc. Natl. Acad. Sci. USA. 95:1998;7151-7156.
18. Dutar P., Nicoll R.A. Classification of muscarinic responses in hippocampus in terms of receptor subtypes and second-messenger systems: electrophysiological studies in vitro. J. Neurosci. 8:1988;4214-4224.
19. Dutar P., Bassant M.H., Senut M.C., Lamour Y. The septohippocampal pathway: structure and function of a central cholinergic system. Physiol. Rev. 75:1995;393-427.
20. AHP in rat CA1 hippocampal neurons. Hippocampus. 6:1996;183-191.
21. Fraser D.D., MacVicar B.A. Cholinergic-dependent plateau potential in hippocampal CA1 pyramidal neurons. J. Neurosci. 16:1996;4113-4128.
22. Fraser D.D., MacVicar B.A. Expression of cholinergic-dependent plateau potentials requires phosphatase-induced dephosphorylation. Soc. Neurosci. Abstr. 22:1996;787.
23. Garthwaite J., Southam E., Boulton C.L., Nielsen E.B., Schmidt K., Mayer B. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one. Mol. Pharmacol. 48:1995;184-188.
24. 2+ current via phosphorylation in a snail neuron. J. Physiol. (Lond.). 485(1):1995;21-28.
25. Halliwell J.V., Adams P.R. Voltage-clamp analysis of muscarinic excitation in hippocampal neurons. Brain Res. 250:1982;71-92.
26. 2+ channels. Pflügers Arch. 429:1995;531-538.
27. Hobbs A.J. Soluble guanylate cyclase: the forgotten sibling. Trends Pharmacol. Sci. 18:1997;484-491.
28. Honkanen R.E., Zwiller J., Moore R.E., Daily S.L., Khatra B.S., Dukelow M., Boynton A.L. Characterization of microcystin-LR, a potent inhibitor of type 1 and type 2A protein phosphatases. J. Biol. Chem. 265:1990;19401-19404.
29. Huerta P.T., Lisman J.E. Heightened synaptic plasticity of hippocampal CA1 neurons during a cholinergically induced rhythmic state. Nature. 364:1993;723-725.
30. 2+ transients. Proc. Natl. Acad. Sci. USA. 87:1990;4083-4087.
31. AHP in CA1 pyramidal neurons. Soc. Neurosci. Abstr. 23:1997;1480.
32. AHP in CA1 pyramidal neurons. Pflügers Arch. 434:1997;R100.
33. Lipsky J.J., Lietman P.S. Aminoglycoside inhibition of a renal phosphatidylinositol phospholipase C. J. Pharmacol. Exp. Ther. 220:1982;287-292.
34. Malenka R.C., Madison D.V., Andrade R., Nicoll R.A. Phorbol esters mimic some cholinergic actions in hippocampal pyramidal neurons. J. Neurosci. 6:1986;475-480.
35. Markram H., Segal M. The inositol 1,4,5-trisphosphate pathway mediates cholinergic potentiation of rat hippocampal neuronal responses to NMDA. J. Physiol. (Lond.). 447:1992;513-533.
36. Michelangeli F., Mezna M., Tovey S., Sayers L.G. Pharmacological modulators of the inositol 1,4,5-trisphosphate receptor. Neuropharmacology. 34:1995;1111-1122.
37. Morton D.B., Bredt D.S. Norepinephrine increases cyclic GMP levels in cerebellar cells from neuronal nitric oxide synthase knockout mice. J. Neurochem. 71:1998;440-443.
38. 2+ changes in hippocampal neurons. Neuron. 6:1991;901-905.
39. 2+-calmodulin kinase II in cholinergic modulation of neuronal responsiveness. J. Neurophysiol. 68:1992;2264-2269.
40. Nicoll R.A. The coupling of neurotransmitter receptors to ion channels in the brain. Science. 241:1988;545-551.
41. Parsons T.D., Obaid A.L., Salzberg B.M. Aminoglycoside antibiotics block voltage-dependent calcium channels in intact vertebrate nerve terminals. J. Gen. Physiol. 99:1992;491-504.
42. + current underlying the slow spike frequency adaptation in hippocampal neurons. Neuron. 11:1993;1023-1035.
43. AHP, by acetylcholine, but not by glutamate, in hippocampal neurons. Pflügers Arch. 431:1996;723-728.
44. AHP by a phosphatase-kinase balance under basal conditions in rat CA1 pyramidal neurons. J. Neurophysiol. 79:1998;3252-3256.
45. Pfeifer A., Aszodi A., Seidler U., Ruth P., Hofmann F., Fässler R. Intestinal secretory defects and dwarfism in mice lacking cGMP-dependent protein kinase II. Science. 274:1996;2082-2086.
46. Pitler T.A., Alger B.E. Activation of the pharmacologically defined M3 muscarinic receptor depolarizes hippocampal pyramidal cells. Brain Res. 534:1990;257-262.
47. Reyes-Harde M., Stanton P.K. Postsynaptic phospholipase C activity is required for the induction of homosynaptic lon-term depression in rat hippocampus. Neurosci. Lett. 252:1998;155-158.
48. Schmidt M.J., Sawyer B.D., Truex L.L., Marshall W.S., Fleisch J.H. LY83583: an agent that lowers intracellular levels of cyclic guanosine 3′,5′-monophosphate. J. Pharmacol. Exp. Ther. 232:1985;764-769.
49. Shen Y., Specht S.M., De Saint Ghislain I., Li R. The hippocampus: a biological model for studying learning and memory. Prog. Neurobiol. 44:1994;485-496.
50. AHP by muscarinic stimulants in rat hippocampal neurons. Eur. J. Neurosci. 4:1992;785-791.
51. Smith R.J., Sam L.M., Justen J.M., Bundy G.L., Bala G.A., Bleasdale J.E. Receptor-coupled signal transduction in human polymorphonuclear neutrophils: effects of a novel inhibitor of phospholipase C-dependent processes on cell responsiveness. J. Pharmacol. Exp. Ther. 253:1990;688-697.
52. Smolenski A., Burkhardt A.M., Eigenthaler M., Butt E., Gambaryan S., Lohmann S.M., Walter U. Functional analysis of cGMP-dependent protein kinases I and II as mediators of NO/cGMP effects. Naunyn-Schmiedeberg's Arch. Pharmacol. 358:1998;134-139.
53. 3H]inositol and stimulated with carbachol. J. Neurochem. 52:1989;713-721.
54. + current in hippocampal pyramidal neurons. Proc. Natl. Acad. Sci. USA. 96:1999;4662-4667.
55. Takahashi M., Tanzawa K., Takahashi S. Adenophostins, newly discovered metabolites of Penicillium brevicompactum, act as potent agonists of the inositol 1,4,5-trisphosphate receptor. J. Biol. Chem. 269:1994;369-372.
56. Tonnaer J.A., Cheung C.L., DeBoer T. cGMP formation and phosphoinositide turnover in rat brain slices are mediated by pharmacologically distinct muscarinic acetylcholine receptors. Eur. J. Pharmacol. 207:1991;183-188.
57. Toselli M., Lang J., Costa T., Lux H.D. Direct modulation of voltage-dependent calcium channels by muscarinic activation of a pertussis toxin-sensitive G-protein in hippocampal neurons. Pflügers Arch. 415:1989;255-261.
58. Wang X., Robinson P.J. Cyclic GMP-dependent protein kinase and cellular signaling in the nervous system. J. Neurochem. 68:1997;443-456.
59. Wera S., Hemmings B.A. Serine/threonine protein phosphatases. Biochem. J. 311:1995;17-29.
60. White R.E., Lee A.B., Shcherbatko A.D., Lincoln T.M., Schonbrunn A., Armstrong D.L. Potassium channel stimulation by natriuretic peptides through cGMP-dependent dephosphorylation. Nature. 361:1993;263-266.
61. Zhang L., Weiner J.L., Carlen P.L. Muscarinic potentiation of IK in hippocampal neurons: electrophysiological characterization of the signal transduction pathway. J. Neurosci. 12:1992;4510-4520.
62. sAHP) in rat hippocampal neurones. J. Physiol. (Lond.). 496(2):1996;395-405.
63. + currents by cGMP-dependent protein kinase in tracheal smooth muscle and Chinese hamster ovary cells. J. Biol. Chem. 271:1996;19760-19767.